135 related articles for article (PubMed ID: 15875187)
1. In vitro sequence-dependent interaction between nedaplatin and paclitaxel in human cancer cell lines.
Tanaka R; Takii Y; Shibata Y; Ariyama H; Qin B; Baba E; Kusaba H; Mitsugi K; Harada M; Nakano S
Cancer Chemother Pharmacol; 2005 Sep; 56(3):279-85. PubMed ID: 15875187
[TBL] [Abstract][Full Text] [Related]
2. In vitro schedule-dependent interaction between paclitaxel and oxaliplatin in human cancer cell lines.
Tanaka R; Ariyama H; Qin B; Takii Y; Baba E; Mitsugi K; Harada M; Nakano S
Cancer Chemother Pharmacol; 2005 Jun; 55(6):595-601. PubMed ID: 15731917
[TBL] [Abstract][Full Text] [Related]
3. In-vitro schedule-dependent interaction between oxaliplatin and 5-fluorouracil in human gastric cancer cell lines.
Qin B; Tanaka R; Shibata Y; Arita S; Ariyama H; Kusaba H; Baba E; Harada M; Nakano S
Anticancer Drugs; 2006 Apr; 17(4):445-53. PubMed ID: 16550003
[TBL] [Abstract][Full Text] [Related]
4. Cell cycle-dependent antagonistic interactions between paclitaxel and gamma-radiation in combination therapy.
Sui M; Dziadyk JM; Zhu X; Fan W
Clin Cancer Res; 2004 Jul; 10(14):4848-57. PubMed ID: 15269161
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel and radiotherapy: sequence-dependent efficacy--a preclinical model.
Niero A; Emiliani E; Monti G; Pironi F; Turci L; Valenti AM; Marangolo M
Clin Cancer Res; 1999 Aug; 5(8):2213-22. PubMed ID: 10473108
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel-induced apoptosis in human gastric carcinoma cell lines.
Chang YF; Li LL; Wu CW; Liu TY; Lui WY; P'eng FK; Chi CW
Cancer; 1996 Jan; 77(1):14-8. PubMed ID: 8630921
[TBL] [Abstract][Full Text] [Related]
7. Differential sensitivity of paclitaxel-induced apoptosis in human esophageal squamous cell carcinoma cell lines.
Faried A; Faried LS; Kimura H; Sohda M; Nakajima M; Miyazaki T; Kato H; Kanuma T; Kuwano H
Cancer Chemother Pharmacol; 2006 Feb; 57(3):301-8. PubMed ID: 16028102
[TBL] [Abstract][Full Text] [Related]
8. Synergistic interaction between oxaliplatin and SN-38 in human gastric cancer cell lines in vitro.
Tanaka R; Ariyama H; Qin B; Shibata Y; Takii Y; Kusaba H; Baba E; Mitsugi K; Harada M; Nakano S
Oncol Rep; 2005 Sep; 14(3):683-8. PubMed ID: 16077975
[TBL] [Abstract][Full Text] [Related]
9. Sequence-dependent antitumor effects of differentiation agents in combination with cell cycle-dependent cytotoxic drugs.
Verheul HM; Qian DZ; Carducci MA; Pili R
Cancer Chemother Pharmacol; 2007 Aug; 60(3):329-39. PubMed ID: 17256134
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel-induced apoptosis is blocked by camptothecin in human breast and pancreatic cancer cells.
Jeansonne DP; Koh GY; Zhang F; Kirk-Ballard H; Wolff L; Liu D; Eilertsen K; Liu Z
Oncol Rep; 2011 May; 25(5):1473-80. PubMed ID: 21331447
[TBL] [Abstract][Full Text] [Related]
11. Oxaliplatin, a potent inhibitor of survivin, enhances paclitaxel-induced apoptosis and mitotic catastrophe in colon cancer cells.
Fujie Y; Yamamoto H; Ngan CY; Takagi A; Hayashi T; Suzuki R; Ezumi K; Takemasa I; Ikeda M; Sekimoto M; Matsuura N; Monden M
Jpn J Clin Oncol; 2005 Aug; 35(8):453-63. PubMed ID: 16024531
[TBL] [Abstract][Full Text] [Related]
12. Schedule-dependent synergism and antagonism between paclitaxel and methotrexate in human carcinoma cell lines.
Kano Y; Akutsu M; Tsunoda S; Furuta M; Yazawa Y; Ando J
Oncol Res; 1998; 10(7):347-54. PubMed ID: 10063968
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel-induced apoptosis may occur without a prior G2/M-phase arrest.
Dziadyk JM; Sui M; Zhu X; Fan W
Anticancer Res; 2004; 24(1):27-36. PubMed ID: 15015572
[TBL] [Abstract][Full Text] [Related]
14. Apoptotic mechanism of paclitaxel-induced cell death in human head and neck tumor cell lines.
Hsiao JR; Leu SF; Huang BM
J Oral Pathol Med; 2009 Feb; 38(2):188-97. PubMed ID: 19200178
[TBL] [Abstract][Full Text] [Related]
15. Anti-tumor activity of heptaplatin in combination with 5-fluorouracil or paclitaxel against human head and neck cancer cells in vitro.
Lee JW; Park JK; Lee SH; Kim SY; Cho YB; Kuh HJ
Anticancer Drugs; 2006 Apr; 17(4):377-84. PubMed ID: 16549994
[TBL] [Abstract][Full Text] [Related]
16. Schedule-dependent synergism and antagonism between pemetrexed and paclitaxel in human carcinoma cell lines in vitro.
Kano Y; Akutsu M; Tsunoda S; Izumi T; Mori K; Fujii H; Yazawa Y; Mano H; Furukawa Y
Cancer Chemother Pharmacol; 2004 Dec; 54(6):505-13. PubMed ID: 15340759
[TBL] [Abstract][Full Text] [Related]
17. 3,3'-diindolylmethane and paclitaxel act synergistically to promote apoptosis in HER2/Neu human breast cancer cells.
McGuire KP; Ngoubilly N; Neavyn M; Lanza-Jacoby S
J Surg Res; 2006 May; 132(2):208-13. PubMed ID: 16580691
[TBL] [Abstract][Full Text] [Related]
18. Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells.
Foroodi F; Duivenvoorden WC; Singh G
Anticancer Drugs; 2009 Feb; 20(2):115-22. PubMed ID: 19209028
[TBL] [Abstract][Full Text] [Related]
19. Antiproliferative effects of rapamycin as a single agent and in combination with carboplatin and paclitaxel in head and neck cancer cell lines.
Aissat N; Le Tourneau C; Ghoul A; Serova M; Bieche I; Lokiec F; Raymond E; Faivre S
Cancer Chemother Pharmacol; 2008 Jul; 62(2):305-13. PubMed ID: 17912526
[TBL] [Abstract][Full Text] [Related]
20. Calcitriol (1,25-dihydroxycholecalciferol) enhances paclitaxel antitumor activity in vitro and in vivo and accelerates paclitaxel-induced apoptosis.
Hershberger PA; Yu WD; Modzelewski RA; Rueger RM; Johnson CS; Trump DL
Clin Cancer Res; 2001 Apr; 7(4):1043-51. PubMed ID: 11309356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]